Raltegravir (RAL) in Neonates: Dosing, Pharmacokinetics (PK), and Safety in HIV-1–Exposed Neonates at Risk of Infection (IMPAACT P1110)-Reference-Cited by-同舟云学术

Raltegravir (RAL) in Neonates: Dosing, Pharmacokinetics (PK), and Safety in HIV-1–Exposed Neonates at Risk of Infection (IMPAACT P1110)

Published:2020-05-01 Issue:1 Volume:84 Page:70-77
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Clarke Diana F.,Acosta Edward P.,Cababasay Mae,Wang Jiajia,Chain Anne,Teppler Hedy,Popson Stephanie,Graham Bobbie,Smith Betsy,Hazra Rohan,Calabrese Kat,Bryson Yvonne,Spector Stephen A.,Lommerse Jos,Mirochnick Mark,

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference20 articles.

1. Raltegravir pharmacokinetics in neonates following maternal dosing;Clarke;J Acquir Immune Defic Syndr,2014

2. The prenatal and postnatal development of UDP-glucuronyltransferase activity towards bilirubin and the effect of premature birth on this activity in the human liver;Kawade;Biochem J.,1981

3. Ontogeny of hepatic glucuronidation; methods and results;Krekels;Curr Drug Metab.,2012

4. Raltegravir in vitro effect on bilirubin binding;Clarke;Pediatr Infect Dis J.,2013

5. A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens;Andersen;Pediatrics.,1956

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human immunodeficiency virus/acquired immunodeficiency syndrome in the infant;Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant;2025

2. HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study;The Lancet HIV;2024-01

3. Updates in the Approach to Pediatric HIV Care and Prevention;Current Treatment Options in Pediatrics;2023-10-13

4. Novel Approaches to Postnatal Prophylaxis to Eliminate Vertical Transmission of HIV;Global Health: Science and Practice;2023-03-31

5. Integrase Strand Transfer Inhibitor Use in Children with Perinatal HIV-1 Infection: A Narrative Review;AIDS Research and Human Retroviruses;2023-01-06